124 related articles for article (PubMed ID: 22831765)
21. Hypercholesterolemia induced cerebral small vessel disease.
Kraft P; Schuhmann MK; Garz C; Jandke S; Urlaub D; Mencl S; Zernecke A; Heinze HJ; Carare RO; Kleinschnitz C; Schreiber S
PLoS One; 2017; 12(8):e0182822. PubMed ID: 28796818
[TBL] [Abstract][Full Text] [Related]
22. The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats.
Jandke S; Garz C; Schwanke D; Sendtner M; Heinze HJ; Carare RO; Schreiber S
Brain Pathol; 2018 Nov; 28(6):844-859. PubMed ID: 30062722
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier and cerebral small vessel disease.
Wardlaw JM
J Neurol Sci; 2010 Dec; 299(1-2):66-71. PubMed ID: 20850797
[TBL] [Abstract][Full Text] [Related]
24. Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model.
Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Suzuki J; Sasaki Y; Nagahama H; Hashi K; Kocsis JD; Honmou O
Neuroscience; 2019 Jun; 408():361-377. PubMed ID: 30999031
[TBL] [Abstract][Full Text] [Related]
25. The expression of osteopontin is increased in vessels with blood-brain barrier impairment.
Iwanaga Y; Ueno M; Ueki M; Huang CL; Tomita S; Okamoto Y; Ogawa T; Ueda N; Maekawa N; Sakamoto H
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):145-54. PubMed ID: 17973907
[TBL] [Abstract][Full Text] [Related]
26. Pre-clinical models of human cerebral small vessel disease: utility for clinical application.
Hainsworth AH; Brittain JF; Khatun H
J Neurol Sci; 2012 Nov; 322(1-2):237-40. PubMed ID: 22698483
[TBL] [Abstract][Full Text] [Related]
27. The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Ueno M; Nakagawa T; Nagai Y; Nishi N; Kusaka T; Kanenishi K; Onodera M; Hosomi N; Huang C; Yokomise H; Tomimoto H; Sakamoto H
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):727-37. PubMed ID: 21418266
[TBL] [Abstract][Full Text] [Related]
28. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
29. Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis.
Zhu H; Li Z; Lv J; Zhao R
Neurol Res; 2018 May; 40(5):381-390. PubMed ID: 29543130
[TBL] [Abstract][Full Text] [Related]
30. Characterization of regional cerebral blood flow and expression of angiogenic growth factors in the frontal cortex of juvenile male SHRSP and SHR.
Jesmin S; Togashi H; Mowa CN; Ueno K; Yamaguchi T; Shibayama A; Miyauchi T; Sakuma I; Yoshioka M
Brain Res; 2004 Dec; 1030(2):172-82. PubMed ID: 15571667
[TBL] [Abstract][Full Text] [Related]
31. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats.
Ueno M; Sakamoto H; Tomimoto H; Akiguchi I; Onodera M; Huang CL; Kanenishi K
Acta Neuropathol; 2004 Jun; 107(6):532-8. PubMed ID: 15042385
[TBL] [Abstract][Full Text] [Related]
32. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function.
Ishida H; Takemori K; Dote K; Ito H
Am J Hypertens; 2006 Jan; 19(1):33-9. PubMed ID: 16461188
[TBL] [Abstract][Full Text] [Related]
33. A raging fire in acute lacunar stroke: inflammation, blood-brain barrier dysfunction and the origin of cerebral microbleeds.
Charidimou A; Werring DJ
J Neurol Sci; 2014 May; 340(1-2):1-2. PubMed ID: 24656599
[No Abstract] [Full Text] [Related]
34. Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior.
Tayebati SK; Tomassoni D; Amenta F
J Neurol Sci; 2012 Nov; 322(1-2):241-9. PubMed ID: 22726353
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary cerebral small-vessel disease].
Nozaki H; Nishizawa M; Onodera O
Nihon Rinsho; 2013 Mar; 71(3):545-54. PubMed ID: 23631251
[TBL] [Abstract][Full Text] [Related]
36. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
Absher PM; Hendley E; Jaworski DM; Taatjes DJ; Sobel BE
Coron Artery Dis; 1999 Sep; 10(6):413-20. PubMed ID: 10474793
[TBL] [Abstract][Full Text] [Related]
37. Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Wang H; Delaney KH; Kwiecien JM; Smeda JS; Lee RM
Clin Invest Med; 1997 Oct; 20(5):327-38. PubMed ID: 9336658
[TBL] [Abstract][Full Text] [Related]
38. [Lacunar stroke and cerebral small vessel disease: advocacy for a recognition].
Firmann M; Medlin F; Hayoz D
Rev Med Suisse; 2014 Apr; 10(425):782-7. PubMed ID: 24791423
[TBL] [Abstract][Full Text] [Related]
39. A novel embolic stroke model resembling lacunar infarction following proximal middle cerebral artery occlusion in beagle dogs.
Liu S; Hu WX; Zu QQ; Lu SS; Xu XQ; Sun L; Zhou WZ; Shi HB
J Neurosci Methods; 2012 Jul; 209(1):90-6. PubMed ID: 22722089
[TBL] [Abstract][Full Text] [Related]
40. Cerebral Venous Collagen Remodeling in a Modified White Matter Lesions Animal Model.
Lin J; Lan L; Wang D; Qiu B; Fan Y
Neuroscience; 2017 Dec; 367():72-84. PubMed ID: 29111361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
